She has a background in neuroscience and molecular psychiatry ... Initial screenings of DNA products may not be enough to prevent problems from arising years down the line. DNA is going to mutate.

This special opportunity led to my encountering the CH12LX B lymphoma line, which had been used ... with a few percent background. Nonetheless, this system was promising, because the cells ...